Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1997 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Jim Rathmann who wrote (6404)	11/2/1997 11:59:00 PM
From: Pancho Villa	Respond to of 9285

Jim. Agree 100% with your view on AVEI. I rather short a stock with poor fundamentals. Any suggestions besides ZITL? Thanks Pancho

To: Jim Rathmann who wrote (6404)	11/19/1997 12:29:00 PM
From: cardiologist to be	Read Replies (1) \| Respond to of 9285

just to add my two cents worth. the technology and stent possessed by avei are so hot that this company will likely get bought out by one of the big boys, likely j&j, because they have the leading third generation stent at the earliest date. fda approval is forthcoming and this company could be bought for 80-100 share. no joke. j&j rep i know owns 60,000 dollars worth of this stock and every cardiologist my cousin knows is buying furiously, risking their margin limit, taking out home equity loans .etc... think twice before you short this stock. overvalued because not yet able to sell in us, but its gotten great press at the last 2 cardiology conferences i've been to and its data is excellent.